pulmonary embolism in 30%3. Mesenteric and portal vein thrombosis which both occurred in this case are less common'':".
It is well recognized that there is an association between tuberous sclerosis and retroperitoneal angioleiomyoma. There does not appear to be an established link between tuberous sclerosis and protein C deficiency. The former is linked to markers on chromosome 9, whereas the gene for protein C has been isolated and assigned to chromosome 2 s.
The clinical response chosen for the combination of bleeding oesophages varices and a hypercoagulable state was to aim to obliterate the varices by injection sclerotherapy and then to maintain anticoagulation with warfarin. The use of danazol as an interim measure until anticoagulation could be safely undertaken was based on the evidence that anabolic steroids increase protein C levels". However, this treatment may not offer effective protection against thrombosis as illustrated by the development of further thrombotic problems in our case. Cyclical hypothermia is an uncommon manifestation of hypothalamic dysfunction. The only effective therapeutic agent is naloxone'<. Bromocriptine, haloperidol, cyproheptadine', dexamphetamine", anti-epileptic drugs l .3,4 and thyroid hormonesv':" are ineffective. We report the successful use of ephedrine.
References

Case report
An 18-year-old woman with hypogonadotrophic hypogonadism was repeatedly admitted in hypothermic coma (core temperature 32.0-33.5°C). Aged 14 years she was treated with thyroxine because of symptoms of lethargy and slow activity with a normal T 3 and T 4 but an elevated thyroid-stimulating hormone (TSH) of 20.7(O.3-6.0)mUIl. Prolactin was 848 mUll without other pituitary/hypothalamic biochemical abnormality and an MRI scan was normal.
When hypothermic, her skin temperature was only I-3°C below core temperature. She had no sense of thermal discomfort and normal thermal sensory thresholds". During rewarming her core temperature did not exceed 35.6°C excluding poikiliothermia.
After one hour's acclimatization in a temperature controlled laboratory at 22±0.5°C, the laboratory was cooled by 4°C for 30 min. Core (tympanic membrane) and skin (great toe pulp) temperature was measured. Thermoregulatory blood flow in the great toe pulp was assessed by laser Doppler flowmetry (Periflux Pf1 Perimed Sweden). Her peripheral skin temperature and blood flow were inappropriately high after cooling when compared to an age/sex matched control (Figure 1 ). There was no response to naloxone-". When taking ephedrine 30 mg four times daily her core temperature increased and there was partial peripheral vasoconstriction, maximal 2 h after a dose (Figure 1 ). She took ephedrine 30 mg four times daily for two 14-day periods at home. Her meantso) oral temperature, compared with the preceding fortnight, increased from 34.6(0.56)OC to 35.6(0.73)OC in the morning, and from 33.9(0.41)OC to 34.9(0.42)OC in the evening. She avoided readmission with hypothermia by taking ephedrine 30 mg four times daily for a week whenever her oral temperature was below the critical value of 34°C at which she became functionally impaired. Thyroxine was withdrawn and her free T 4 and free T 3 remained normal. Her TSH rose to 26.7 mUll (alpha 
Discussion
Spontaneous cyclical hypothermia is a rare heterogeneous disorder, related to posterior hypothalamic damages. It is associated with congenital or acquired central nervous system abnormalities, especially corpus callosum agenesis (Schapiro's syndrome), diencephalic epilepsy, abnormalities of water metabolism and other hypothalamic endocrine dysfunction', The absence of a structural abnormality is unusual.
Body temperature is regulated by a hypothalamic thermostats. In our patient, the thermoregulatory set point is abnormally low. This is manifest by inappropriate vasodilation, a lack of thermal discomfort, an inappropriate behavioural response to cold and the failure to shiver unless cooled further. The abnormality of the thermoregulatory set point is thought to be related to a decreased sodium/calcium ratio in the hypothalamic temperature sensor, which is influenced by abnormal neural or neuropeptide activity.
The. presence of inappropriate peripheral vasodilation whilst hypothermic, stimulated us to use ephedrine which is a long acting orally active sympathomimetic", Ephedrine releases noradrenaline from adrenergic nerve terminals and can also directly stimulate adrenergic receptors", Noradrenaline induces peripheral vasoconstriction which reduces heat loss and is involved in non-shivering thermogenesis. Tachyphylaxis of the peripheral actions of ephedrine may limit the duration of treatment. In our experience ephedrine was less effective after 14 days.
Adrenergic neurones in the hypothalamus are thought to be the effector pathway for heat dissipation. Ephedrine has less central action than amphetamine" which is ineffective in this condition",
The hypothalamic centres which control TSH secretion are in close proximity to the posterior hypothalamus. Elevation
Meeting reports
Journal of the Royal Society of Medicine Volume 84 December 1991 753 of TSH with normal levels of thyroid hormones is reported in two cases':". The increase in TSH in this case may be an adaptive response to hypothermia although this response is ill-defined in man!'. Professor David Musto (Yale University School of Medicine, USA) reviewed the history of cocaine, particularly the American experience. There have been two cocaine epidemics which show many similarities, with initial enthusiastic acceptance of cocaine followed by intense public rejection, and a move from tolerance to intolerance. A major difference is that severe laws Were in place at the beginning of the second epidemic whereas they were enacted only as the first declined. In the late 19th century cocaine was advocated as a general 'tonic', with stimulant and therapeutic properties and without adverse effects. In Britain, it was restricted, but the image of cocaine changed only gradually in the USA, and laws regulating it were not passed until the early 1900s, with the first national law in 1914. Illicit sales of cocaine then rose, but its use gradually disappeared and was no longer a serious problem by the 1930sonly to reappear in the USA in the late 1960s, when it was again seen as a tonic, and experts commonly took a lenient attitude. However, when crack, a smokable, low cost form of cocaine, appeared about 1985 the public became alarmed, and anti-cocaine laws were strengthened.
The drug problem is commonly thought to be a serious contemporary problem, but past history is relevant. Both the European and American experiences are worthwhile fields for investigation.
In introducing the subject of pharmacotherapy, Dr Herbert Kleber (Office of National Drug Control Policy, USA) described the sequence of events and phases through which the cocaine user goes. The onset of action is rapid, with euphoria and good short-term effects, followed by their rapid reversal. More cocaine is takenbut in larger amounts to achieve the same effects. The usual pattern is binge use, with the cycle repeated over several hours or days, followed by a pause before there is again a craving for cocaine. The individual may become addicted, with neurological changes persisting in the brain for a significant period. 
